Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Czechia Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20072
20082
20101
20112
20121
20131
20142
20152
20162
20172
20181
20193
20206
20212
20222
20234
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting10
Terminated6
Unknown status6
Recruiting5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Celgene5
Novartis Pharmaceuticals5
Bristol-Myers Squibb3
Takeda3
Astex Pharmaceuticals, Inc.2
Institute of Hematology and Blood Transfusion, Czech Republic2
AbbVie1
Agios Pharmaceuticals, Inc.1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes45
Leukemia, Myeloid, Acute13
Leukemia, Myelomonocytic, Chronic10
Anemia8
Anemia, Refractory, with Excess of Blasts8
Leukemia6
Anemia, Refractory4
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Recurrence3
Thrombocytopenia3

Trials

Showing 76 to 45 of 45. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.